According to ModivCare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0709895. At the end of 2022 the company had a P/E ratio of -39.7.
Year | P/E ratio | Change |
---|---|---|
2022 | -39.7 | -86.88% |
2021 | -303 | -606.46% |
2020 | 59.8 | -134.33% |
2019 | -174 | 462.6% |
2018 | -30.9 | -263.71% |
2017 | 18.9 | 155.78% |
2016 | 7.39 | -33.23% |
2015 | 11.1 | -57.49% |
2014 | 26.0 | 46.74% |
2013 | 17.7 | -32.14% |
2012 | 26.1 | 143.15% |
2011 | 10.8 | 19.74% |
2010 | 8.98 | -8.52% |
2009 | 9.81 | -8458.54% |
2008 | -0.1174 | -100.5% |
2007 | 23.3 | -24.11% |
2006 | 30.6 | 4.32% |
2005 | 29.4 | 6.42% |
2004 | 27.6 | -118.67% |
2003 | -148 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.